StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
RKDA$0.92-5.04%
Fair $0.92+0.0%

RKDA

Arcadia Biosciences, Inc.

Consumer Defensive / Packaged FoodsNasdaqCM

$0.92

-0.05 (-5.04%)

Fairly Valued+0.0%Fair Value $0.92Fund rank 28/100 · Data gapFallback financials|
SA 6/F
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $-9.6M · quality 59.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 41/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

6/100

F

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 12Warnings: 1unknown: 12
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -56.5%, below the 5% threshold
Thesis & Journal · RKDALocal privado en este navegador · Arcadia Biosciences, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-56.5%

↓

Gross Margin

36.2%

↑

Debt/Equity

N/A

•
52-Week Range$1
$1$7

TradingView lightweight chart

RKDA price, volumen y niveles de valoración

Último $0.916Periodo -100.0%
Fair value: $0.916

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2014–2025 · 11 años de histórico normalizado

Revenue CAGR

-3.2%

FCF CAGR

—

FCF margin

-97.6%

FCF / Net income

2.03x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.9M · net income $-2.3M · FCF $-4.7M

2014-FY → 2025-FY

Gross margin

36.2%— pts

Operating margin

-205.7%+11.3% pts

Net margin

-48.1%+214.5% pts

FCF margin

-97.6%— pts
MetricTTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Income Statement
Revenue$4.9M$4.9M$5.0M$4.5M$7.4M$6.8M$8.0M$1.2M$1.5M$4.0M$3.2M$5.4M$7.0M
Net Income$-2.3M$-2.3M$-7.0M$-14.0M$-15.4M$-14.7M$-4.7M$-28.8M$-13.5M$-15.7M$-19.6M$-18.0M$-18.3M
EBITDA$-10.0M$-10.0M$-7.5M$-5.7M$-14.7M———$-16.7M$-14.0M$-18.3M$-15.3M$-14.8M
EPS-1.71-1.71-5.17-11.29-25.65-27.56———————
Gross Margin36.2%36.2%41.3%51.2%17.8%————————
Operating Margin-205.7%-205.7%-150.9%-135.1%-205.3%-524.0%-159.0%-1657.9%-1152.3%-355.6%-584.1%-287.5%-217.0%
Net Margin-48.1%-48.1%-139.5%-313.9%-207.3%-216.2%-57.9%-2464.1%-920.8%-390.1%-615.6%-331.7%-262.7%
Balance Sheet
Debt/Equity——0.020.080.100.000.080.010.000.001.130.62-0.10
Current Ratio3.793.79———————————
Cash Flow
Free Cash Flow$-4.7M$-4.7M$-9.6M$-15.3M$-14.0M$-26.9M$-32.6M$-18.7M$-13.9M$-14.0M———
Returns
ROE-56.5%-56.5%-113.1%-108.9%-73.1%-47.1%-16.8%-373.8%-105.2%-196.2%-88.4%-44.6%21.6%
Valuation
P/B0.300.301.390.260.38————————
Growth & Yield
Revenue Growth-3.7%-3.7%13.3%-40.0%—-15.6%587.3%-20.2%-63.6%26.3%-41.1%-22.5%—
EPS Growth66.9%66.9%54.2%56.0%—————————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -80.5%

Total return

-80.5%

Start / end P/E

n/dx → n/dx

EPS bridge

-5.17 → -1.71

Residual

-80.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-80.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.